Novavax Inc (NVAX)
8.05
-0.01
(-0.12%)
USD |
NASDAQ |
Nov 21, 16:00
7.95
-0.10
(-1.24%)
After-Hours: 17:35
Novavax Shareholders Equity (Quarterly): -526.44M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -526.44M |
June 30, 2024 | -431.71M |
March 31, 2024 | -867.08M |
December 31, 2023 | -716.93M |
September 30, 2023 | -678.35M |
June 30, 2023 | -754.52M |
March 31, 2023 | -895.58M |
December 31, 2022 | -634.08M |
September 30, 2022 | -565.98M |
June 30, 2022 | -416.95M |
March 31, 2022 | 65.32M |
December 31, 2021 | -351.67M |
September 30, 2021 | 461.34M |
June 30, 2021 | 745.56M |
March 31, 2021 | 1.039B |
December 31, 2020 | 627.21M |
September 30, 2020 | 106.44M |
June 30, 2020 | 184.53M |
March 31, 2020 | -23.97M |
December 31, 2019 | -186.02M |
September 30, 2019 | -189.84M |
June 30, 2019 | -185.49M |
March 31, 2019 | -150.58M |
December 31, 2018 | -167.94M |
September 30, 2018 | -126.68M |
Date | Value |
---|---|
June 30, 2018 | -87.71M |
March 31, 2018 | -99.37M |
December 31, 2017 | -101.73M |
September 30, 2017 | -74.15M |
June 30, 2017 | -59.06M |
March 31, 2017 | -29.10M |
December 31, 2016 | -5.546M |
September 30, 2016 | 49.78M |
June 30, 2016 | 110.12M |
March 31, 2016 | 185.43M |
December 31, 2015 | 292.67M |
September 30, 2015 | 367.02M |
June 30, 2015 | 387.60M |
March 31, 2015 | 399.71M |
December 31, 2014 | 229.62M |
September 30, 2014 | 261.65M |
June 30, 2014 | 281.73M |
March 31, 2014 | 191.06M |
December 31, 2013 | 203.23M |
September 30, 2013 | 216.57M |
June 30, 2013 | 69.23M |
March 31, 2013 | 77.57M |
December 31, 2012 | 80.24M |
September 30, 2012 | 61.38M |
June 30, 2012 | 61.08M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-895.58M
Minimum
Mar 2023
1.039B
Maximum
Mar 2021
-190.99M
Average
-384.31M
Median
Shareholders Equity (Quarterly) Benchmarks
Pfizer Inc | 92.29B |
Moderna Inc | 11.93B |
Inovio Pharmaceuticals Inc | 73.54M |
Baxter International Inc | 7.872B |
Halozyme Therapeutics Inc | 452.70M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.712B |
Total Liabilities (Quarterly) | 2.239B |
Debt to Equity Ratio | -0.3215 |
Current Ratio | 0.9345 |
Net Debt Paydown Yield | -0.02% |